CORTESINI, Raffaello
 Distribuzione geografica
Continente #
NA - Nord America 2.458
EU - Europa 1.054
AS - Asia 367
SA - Sud America 37
AF - Africa 8
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.927
Nazione #
US - Stati Uniti d'America 2.433
IT - Italia 485
UA - Ucraina 194
IN - India 178
SE - Svezia 145
CN - Cina 116
FI - Finlandia 105
SG - Singapore 42
DE - Germania 37
AR - Argentina 35
GB - Regno Unito 23
CA - Canada 21
IR - Iran 20
BG - Bulgaria 15
IE - Irlanda 14
AT - Austria 12
TG - Togo 8
FR - Francia 7
TR - Turchia 6
BE - Belgio 4
MX - Messico 4
CH - Svizzera 3
DK - Danimarca 3
TW - Taiwan 3
CL - Cile 2
NL - Olanda 2
NZ - Nuova Zelanda 2
RO - Romania 2
SI - Slovenia 2
BD - Bangladesh 1
EU - Europa 1
GR - Grecia 1
TH - Thailandia 1
Totale 3.927
Città #
Fairfield 345
Woodbridge 245
Chandler 176
Houston 145
Ashburn 144
Ann Arbor 131
Princeton 119
Seattle 110
Cambridge 93
Wilmington 93
Plano 89
Jacksonville 79
Dearborn 67
Beijing 61
Rome 54
Millbury 51
Boston 45
Lawrence 43
Federal 35
Andover 30
San Diego 23
San Paolo di Civitate 23
Norwalk 19
Milan 18
Singapore 18
Helsinki 16
Sofia 15
Dublin 14
Ottawa 12
Bremen 11
Hefei 11
Vienna 11
Boardman 10
Zanjan 10
Nanjing 9
Toronto 9
Grafing 8
Lomé 8
San Mateo 8
Bühl 7
Napoli 7
Torino 7
Falls Church 6
Istanbul 6
New York 6
Pavia 6
Des Moines 5
Kunming 5
Palermo 5
Bari 4
Brussels 4
Guangzhou 4
Jinan 4
London 4
Mexico City 4
Redmond 4
Treviso 4
Angri 3
Birmingham 3
Cava De' Tirreni 3
Changsha 3
Hebei 3
Jian 3
Leawood 3
Murano 3
Nanchang 3
Parma 3
Pisa 3
Romford 3
Siracusa 3
Southend 3
Verona 3
Anzio 2
Auckland 2
Augusta 2
Bologna 2
Castelnuovo Rangone 2
Catanzaro 2
Cerreto Sannita 2
Ferentino 2
Florence 2
Frankfurt am Main 2
Henderson 2
Isernia 2
Kashan 2
Ljubljana 2
Loreto 2
Los Angeles 2
Meda 2
Montesano Sulla Marcellana 2
New Delhi 2
Padova 2
Panettieri 2
Quzhou 2
Rieti 2
Rimini 2
Riomaggiore 2
Sacramento 2
Santa Lucia Di Piave 2
Shenyang 2
Totale 2.601
Nome #
MONITORAGGIO DEL LIVELLO EMATICO DI TACROLIMUS: CARATTERISTICHE DEL DOSAGGIO IN IMx 296
Il PRELIEVO MULTI-ORGANO:TECNICA CHIRURGICA 251
ANAESTHESIA FOR LIVER TRANSPLANTATION IN CYSTIC FIBROSIS PATIENTS 103
Interleukin-10 induces the upregulation of the inhibitory receptor ILT4 in monocytes from HIV positive individuals 81
Tolerogenic dendritic cells in cancer, transplantation, and autoimmune diseases 80
Perfusion time anuria and nephrotoxicity in cadaveric renal transplant. 77
EFFICIENCY OF TRANSGENESIS USING SPERM-MEDIATED GENE TRANSFER :GENERATION OF hDAF TRANSGENIC PIGS 76
The role of preoperative investigations in predicting difficult laparoscopic cholecystectomies. Results in 200 consecutive cases. 75
The organizational model of the Interregional Transplant Agency Organizzazione Centro-Sud Trapianti 72
Organizzazione Centro-Sud Trapianti: Outcome analysis 1999 to 2002 69
Improved results with lung transplantation for cystic fibrosis 67
IMMUNOSUPPRESSIVE THERAPY IN HIGH RISK PATIENTS 67
Sperm-mediated gene transfer: Production of pigs transgenic for a human regulator of complement activation 67
Transplantation activity in the Organizzazione Centro-Sud Trapianti: A retrospective study from 1999 to March 2004 66
Immunoglobulin-like transcript 3: A crucial regulator of dendritic cell function 66
Liver transplantation: expanding the donor pool 65
Opsonic activity of intravenous immunoglobulins used for prophylaxis of infections in transplanted recipients 64
Suppression of xenogeneic graft-versus-host disease by treatment with immunoglobulin-like transcript 3-Fc 63
Volumetric monitoring in multiorgan donor and related lung transplant recipients. 61
94 CONSECUTIVE LIVING UNRELATED KIDNEY TRANSPLANTS : 8 YEARS GRAFT AND PATIENT SURVIVAL 61
Hemodynamic-volumetric versus pulmonary artery catheter monitoring during anesthesia for liver transplantation 59
CLINICAL EXPERIENCE WITH CYCLOSPORIN AT THE ROME UNIVERSITY HOSPITAL. 58
THE IMPACT OF TIPSS ON LIVER TRANSPLANTATION 57
Tailoring of immunosuppression in renal and liver allograft recipients displaying donor specific T-suppressor cells 57
Epatotossicità da Ciclosporina nel trapianto di fegato 55
94 CONSECUTIVE LIVING UNRELATED KIDNEY TRANSPLANTS: 8 YEARS GRAFT AND PATIENT ACTUARIAL SURVIVAL 54
ORGAN ALLOGRAFT RECIPIENTS DEVELOP HLA CLASS I-SPECIFIC T SUPPRESSOR CELLS 54
Alternative laparoscopic management of perforated peptic ulcers. 51
PROTECTION FROM COMPLEMENT-MEDIATED INJURY IN LIVERS AND KIDNEYS OF TRANSGENIC MICE EXPRESSING HUMAN COMPLEMENT REGULATORS 51
ASPETTI ETICI DEGLI XENOTRAPIANTI 51
Pediatric renal transplantation: Personal experience 49
Pregnancy after liver transplantation: Report of 8 new cases and review of the literature 47
CYCLOSPORIN A IN KIDNEY ALLOGRAFT WITH LONG-TERM PRESERVATION. 46
Cadaveric organ donors and malignancy. Our experience in Italy 43
Tacrolimus as cornerstone immunosuppressant in kidney transplantation 42
BENCH SURGERY FOR MULTIPLE RENAL ARTERIES IN KIDNEY TRANSPLANTATION FROM LIVING DONOR 41
RESULTS WITH DONOR KIDNEYS PRESERVED LONGER THAN 4O HOURS 40
Valutazione della necrosi tubulare acuta quale fattore predisponente alla nefrotossicità da ciclosporina 39
Immunological studies of renal allograft recipients treated with total lymphoid irradiation. 39
MULTIPLE ABDOMINAL VISCERAL TRANSPLANTATION: CLINICAL EXPERIENCE OF ORGAN PRESERVATION BY UNIVERSITY OF WISCONSIN (UW) SOLUTION 38
EVOLUTION OF SURGICAL TECHNIQUE:FROM RENAL TO MULTIORGAN TRANSPLANTATION. PERSONAL EXPERIENCE 38
MULTIPLE ORGAN HARVESTING: EVOLUTION OF SURGICAL TECHNIQUE. PERSONAL EXPERIENCE 38
PROLONGED LIVER COLD ISCHEMIA TIME WITH UNIVERSITY OF WISCONSIN SOLUTION AND INCIDENCE OF DELAYED GRAFT FUNCTION AFTER HEPATIC TRANSPLANTATION: A SINGLE CENTER EXPERIENCE 37
Urinary exfoliative cytology in kidney allografts under cyclosporine therapy. 37
HEART-TRANSPLANTATION IN CHILDREN - INITIAL EXPERIENCE AT UNIVERSITY-OF-ROME 37
LIVING UNRELATED KIDNEY TRANSPLANTATION 36
Cytological analysis of preservation injury in liver transplantation. 35
hDAF TRANSGENIC PIG GENERATION: A NEW SOURCE OF ORGANS FOR XENOTRANSPLANTATION 35
LONG-TERM FOLLOW-UP OF KIDNEY GRAFTS IN HIGH-RISK PATIENTS UNDER TLI AND CSA THERAPY 34
Nefrotossicità da Ciclosporina nel trapianto di rene: nostra esperienza di monitoraggio post-operatorio con citologia esfoliativa urinaria e citologia per aspirazione con ago sottile 33
INDICAZIONI AL TRAPIANTO RENALE CLINICO ESPERIENZE SU 263 CASI 32
LONG-TERM PRESERVATION. PRIMARY ANURIA, NEPHROTOXICITY AND GRAFT SURVIVAL IN KIDNEY TRANSPLANT ON CYCLOSPORINE 32
HDAF EXPRESSION IN HEARTS OF TRANSGENIC PIGS OBTAINED BY SPERM-MEDIATED GENE TRANSFER 32
KIDNEY TRANSPLANTATION IN ELDERLY PATIENTS 31
ASPETTATIVA E QUALITA' DI VITA DOPO TRAPIANTO DI ORGANO 30
Epidemiologia ed istologia dei tumori nei trapiantati 30
LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA(HCC): A 13 YEARS SINGLE CENTER EXPERIENCE 28
MULTIORGAN TRANSPLANTATION IN LIVER TUMOURS: ITALIAN EXPERIENCE 28
IS DELTA INFECTION AN AGGRAVATING FACTOR IN LIVER ALLOGRAFT RECIPIENTS? 28
LE INFEZIONI NEI TRAPIANTI D'ORGANO 27
TRAPIANTO DI FEGATO NELLA CIRROSI HBV-HDV CORRELATA: RUOLO DELLA IMMUNOPROFILASSI. ESPERIENZA PERSONALE 27
LA PREPARAZIONE DEL RICEVENTE AL TRAPIANTO RENALE CLINICO 27
LIVING UNRELATED KIDNEY TRANSPLANTATION: A 12-YEAR SINGLE CENTER EXPERIENCE 26
IL RUOLO DELLA TIPS NEL TRATTAMENTO DELL'IPERTENSIONE PORTALE NEI PAZIENTI CIRROTICI IN ATTESA DI TRAPIANTO DI FEGATO 26
Living-unrelated kidney transpantation: a real source in the Cyclosporine era. 26
I TRAPIANTI IN ONCOLOGIA 24
MULTIVISCERAL CLUSTER TRANSPLANTATION: A PRELIMINARY EXPERIENCE 23
TRAPIANTO DI FEGATO NELLE DILATAZIONI CONGENITE DELL'ALBERO BILIARE 22
MULTIVARIATE FACTORS INFLUENCING ARTERIAL PATENCY IN LIVER TRANSPLANTATION:PERSONAL EXPERIENCE 22
CONVERSION FROM SANDIMMUN TO SANDIMMUN NEORAL:A SINGLE CENTRE EXPERIENCE 22
IL TRAPIANTO DI RENE E DI FEGATO NELL'ANZIANO.ESPERIENZE PERSONALI 21
IL TRAPIANTO MULTIORGANO IN ONCOLOGIA: RISULTATI PRELIMINARI 20
ISSUES IN ORGAN DONATION:LIVING UNRELATED KIDNEY TRANSPLANTATION 20
INGEGNERIA GENETICA NEL FUTURO DEI TRAPIANTI.ESPERIENZA MONDIALE E PERSONALE 19
TRAPIANTO DI FEGATO IN 40 PAZIENTI CON CARCINOMA EPATOCELLULARE IN STADIO III-IV: FOLLOW-UP A 7 ANNI DAL TRAPIANTO 19
IL MARS NEL TRATTAMENTO DELL'INSUFFICIENZA EPATICA ACUTA. ESPERIENZA MONOCENTRICA SU 45 CASI. 19
TERAPIA DELL'EPATOCARCINOMA: IL RUOLO DEL TRAPIANTO DI FEGATO 18
MULTIORGAN TRANSPLANTATION IN LIVER TUMORS: ITALIAN EXPERIENCE 18
IL TRAPIANTO DI RENE:ASPETTI CHIRURGICI PARTICOLARI 18
MONOETHYLGLYCINEXYLIDIDE CLEARANCE TEST:ITS ROLE AS A PART OF BRAIN DEAD DONORS EVALUATION FOR LIVER TRANSPLANTATION 16
IL TRAPIANTO DI FEGATO IN EUROPA 16
PRELIEVI D'ORGANO PER I TRAPIANTI: LA CONSERVAZIONE DEL FEGATO 16
MOFETIL MYCOPHENOLATE FOR PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION. A PRELIMINARY,SINGLE-CENTER EXPERIENCE 16
TERAPIA IMMUNOSOPPRESSIVA NEL TRAPIANTO DI FEGATO: ESPERIENZA SU 50 CASI 16
Valutazione della funzione cardiaca in pazienti pediatrici prima e dopo trapianto di rene: follow-up a breve termine 15
I TRAPIANTI MULTIVISCERALI 15
I TRAPIANTI MULTIVISCERALI 15
IL RIGETTO ACUTO DOPO TRAPIANTO RENALE: RUOLO DEL MICOFENOLATO MOFETILE 15
IL TRAPIANTO INTESTINALE E MULTIVISCERALE: TRATTAMENTO PRE- E POST-OPERATORIO DEL RICEVENTE.STRATEGIE,TATTICHE E TECNICHE CHIRURGICHE DI TRAPIANTO 10
Hemodynamic and metabolic effects of transjugular intrahepatic portosystemic shunt (TIPS) during anesthesia for orthotopic liver transplantation 4
Totale 4.027
Categoria #
all - tutte 9.511
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.511


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019187 0 0 0 0 0 0 0 0 0 0 104 83
2019/2020785 129 21 10 41 50 133 101 96 67 75 45 17
2020/2021324 48 34 9 36 17 25 13 39 20 45 25 13
2021/2022862 2 54 70 25 126 11 8 76 83 72 144 191
2022/2023735 210 114 59 76 61 63 16 39 68 7 10 12
2023/2024245 24 36 18 45 17 22 8 16 2 38 19 0
Totale 4.027